PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.54
ESG score 80-90% of MDGL's 64.75. Walter Schloss would scrutinize governance quality and regulatory exposure.
57.89
Environmental score 80-90% of MDGL's 67.94. Walter Schloss would scrutinize carbon exposure and transition planning.
58.17
Similar social score to MDGL's 58.60. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
56.57
Governance score 80-90% of MDGL's 67.70. Walter Schloss would scrutinize management accountability and board independence.